HEADER ISOMERASE/TRANSFERASE 17-FEB-12 4DRI TITLE CO-CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF FKBP51, RAPAMYCIN AND THE TITLE 2 FRB FRAGMENT OF MTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FKBP51 FK1 DOMAIN, UNP RESIDUES 1-140; COMPND 5 SYNONYM: PPIASE FKBP5, 51 KDA FK506-BINDING PROTEIN, 51 KDA FKBP, COMPND 6 FKBP-51, 54 KDA PROGESTERONE RECEPTOR-ASSOCIATED IMMUNOPHILIN, COMPND 7 ANDROGEN-REGULATED PROTEIN 6, FF1 ANTIGEN, FK506-BINDING PROTEIN 5, COMPND 8 FKBP-5, FKBP54, P54, HSP90-BINDING IMMUNOPHILIN, ROTAMASE; COMPND 9 EC: 5.2.1.8; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: SERINE/THREONINE-PROTEIN KINASE MTOR; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: FRB DOMAIN, UNP RESIDUES 2025-2114; COMPND 15 SYNONYM: FK506-BINDING PROTEIN 12-RAPAMYCIN COMPLEX-ASSOCIATED COMPND 16 PROTEIN 1, FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN, MAMMALIAN COMPND 17 TARGET OF RAPAMYCIN, MTOR, MECHANISTIC TARGET OF RAPAMYCIN, RAPAMYCIN COMPND 18 AND FKBP12 TARGET 1, RAPAMYCIN TARGET PROTEIN 1; COMPND 19 EC: 2.7.11.1; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AIG6, FKBP5, FKBP51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX-HTA; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: FRAP, FRAP1, FRAP2, MTOR, RAFT1, RAPT1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PPROEX-HTA KEYWDS FK-506 BINDING DOMAIN, HSP90 COCHAPERONE, IMMUNOPHILIN, PEPTIDYL- KEYWDS 2 PROLYL ISOMERASE, MAMMALIAN TARGET OF RAPAMYCIN, KINASE, SIGNALLING, KEYWDS 3 IMMUNOSUPPRESSION, CANCER, ISOMERASE-TRANSFERASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.M.MAERZ,A.BRACHER,F.HAUSCH REVDAT 3 13-SEP-23 4DRI 1 REMARK SEQADV REVDAT 2 27-MAR-13 4DRI 1 JRNL REVDAT 1 06-FEB-13 4DRI 0 JRNL AUTH A.M.MARZ,A.K.FABIAN,C.KOZANY,A.BRACHER,F.HAUSCH JRNL TITL LARGE FK506-BINDING PROTEINS SHAPE THE PHARMACOLOGY OF JRNL TITL 2 RAPAMYCIN. JRNL REF MOL.CELL.BIOL. V. 33 1357 2013 JRNL REFN ISSN 0270-7306 JRNL PMID 23358420 JRNL DOI 10.1128/MCB.00678-12 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.05 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 39213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2062 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2695 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 151 REMARK 3 BIN FREE R VALUE : 0.2570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1718 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 223 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.77 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.069 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.071 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.044 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.294 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1911 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2580 ; 1.546 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 233 ; 6.778 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 82 ;30.618 ;24.390 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 345 ;13.009 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;16.590 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 266 ; 0.100 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1451 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 859 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1355 ; 0.312 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 177 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.203 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.082 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1152 ; 0.954 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1803 ; 1.435 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 854 ; 2.281 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 777 ; 3.471 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 9 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 20 A 43 REMARK 3 ORIGIN FOR THE GROUP (A): 34.8455 65.9335 21.2544 REMARK 3 T TENSOR REMARK 3 T11: -0.0860 T22: -0.0760 REMARK 3 T33: -0.1355 T12: 0.0274 REMARK 3 T13: -0.0211 T23: 0.0510 REMARK 3 L TENSOR REMARK 3 L11: 5.7827 L22: 5.0500 REMARK 3 L33: 7.7960 L12: -2.5658 REMARK 3 L13: -5.1348 L23: 2.2414 REMARK 3 S TENSOR REMARK 3 S11: 0.0275 S12: 0.2902 S13: 0.2152 REMARK 3 S21: -0.1883 S22: 0.0796 S23: 0.1687 REMARK 3 S31: -0.2522 S32: -0.3925 S33: -0.1072 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 44 A 69 REMARK 3 ORIGIN FOR THE GROUP (A): 39.0713 54.8549 26.2497 REMARK 3 T TENSOR REMARK 3 T11: -0.1349 T22: -0.1239 REMARK 3 T33: -0.1569 T12: 0.0114 REMARK 3 T13: 0.0339 T23: 0.0064 REMARK 3 L TENSOR REMARK 3 L11: 5.2036 L22: 3.7262 REMARK 3 L33: 3.6289 L12: 1.8382 REMARK 3 L13: 2.1205 L23: 1.1802 REMARK 3 S TENSOR REMARK 3 S11: -0.1268 S12: 0.2177 S13: -0.0691 REMARK 3 S21: -0.0386 S22: 0.1042 S23: -0.1204 REMARK 3 S31: -0.0505 S32: 0.0932 S33: 0.0226 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 70 A 114 REMARK 3 ORIGIN FOR THE GROUP (A): 35.4805 55.2846 27.2464 REMARK 3 T TENSOR REMARK 3 T11: -0.1507 T22: -0.1111 REMARK 3 T33: -0.1490 T12: 0.0084 REMARK 3 T13: -0.0032 T23: -0.0081 REMARK 3 L TENSOR REMARK 3 L11: 1.8786 L22: 2.5668 REMARK 3 L33: 3.0720 L12: 0.5031 REMARK 3 L13: -0.1535 L23: -0.0344 REMARK 3 S TENSOR REMARK 3 S11: -0.0652 S12: 0.0486 S13: -0.1094 REMARK 3 S21: -0.0698 S22: 0.0918 S23: -0.0274 REMARK 3 S31: 0.0397 S32: -0.0953 S33: -0.0266 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 115 A 140 REMARK 3 ORIGIN FOR THE GROUP (A): 38.0791 56.6678 32.2343 REMARK 3 T TENSOR REMARK 3 T11: -0.1310 T22: -0.1066 REMARK 3 T33: -0.1313 T12: 0.0194 REMARK 3 T13: -0.0109 T23: -0.0013 REMARK 3 L TENSOR REMARK 3 L11: 1.6112 L22: 2.7379 REMARK 3 L33: 6.3853 L12: 0.4243 REMARK 3 L13: 0.9235 L23: 2.0459 REMARK 3 S TENSOR REMARK 3 S11: 0.0508 S12: -0.0984 S13: -0.0666 REMARK 3 S21: 0.1874 S22: -0.0641 S23: -0.0674 REMARK 3 S31: 0.1763 S32: -0.3625 S33: 0.0133 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2017 B 2034 REMARK 3 ORIGIN FOR THE GROUP (A): 27.1857 32.3570 40.4655 REMARK 3 T TENSOR REMARK 3 T11: -0.0541 T22: 0.0289 REMARK 3 T33: 0.1622 T12: -0.0631 REMARK 3 T13: -0.0216 T23: 0.0246 REMARK 3 L TENSOR REMARK 3 L11: 4.8978 L22: 9.3465 REMARK 3 L33: 3.6990 L12: 2.4775 REMARK 3 L13: 2.1188 L23: 1.4378 REMARK 3 S TENSOR REMARK 3 S11: 0.1940 S12: 0.1930 S13: -0.6070 REMARK 3 S21: 0.0571 S22: -0.0234 S23: 0.7584 REMARK 3 S31: 0.4538 S32: -0.5240 S33: -0.1706 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2035 B 2056 REMARK 3 ORIGIN FOR THE GROUP (A): 33.3731 42.4235 47.9172 REMARK 3 T TENSOR REMARK 3 T11: -0.0450 T22: 0.0006 REMARK 3 T33: -0.0377 T12: 0.0267 REMARK 3 T13: 0.0454 T23: 0.0366 REMARK 3 L TENSOR REMARK 3 L11: 3.9168 L22: 7.5080 REMARK 3 L33: 3.7775 L12: -0.2939 REMARK 3 L13: 0.3147 L23: 0.1219 REMARK 3 S TENSOR REMARK 3 S11: -0.0342 S12: -0.4333 S13: -0.1551 REMARK 3 S21: 0.8580 S22: 0.1486 S23: 0.4226 REMARK 3 S31: -0.1281 S32: -0.2725 S33: -0.1145 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2057 B 2074 REMARK 3 ORIGIN FOR THE GROUP (A): 35.9234 23.2026 38.7242 REMARK 3 T TENSOR REMARK 3 T11: 0.1602 T22: -0.1025 REMARK 3 T33: 0.3308 T12: -0.0153 REMARK 3 T13: -0.0172 T23: -0.1025 REMARK 3 L TENSOR REMARK 3 L11: 10.9152 L22: 11.8676 REMARK 3 L33: 6.1100 L12: 3.5423 REMARK 3 L13: -2.0648 L23: 4.7960 REMARK 3 S TENSOR REMARK 3 S11: -0.2451 S12: 0.0983 S13: -1.2029 REMARK 3 S21: 0.4997 S22: -0.0606 S23: 0.1842 REMARK 3 S31: 0.9537 S32: -0.3687 S33: 0.3057 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2075 B 2112 REMARK 3 ORIGIN FOR THE GROUP (A): 42.9539 39.6217 42.3499 REMARK 3 T TENSOR REMARK 3 T11: -0.1267 T22: -0.1462 REMARK 3 T33: -0.0696 T12: 0.0165 REMARK 3 T13: -0.0090 T23: -0.0067 REMARK 3 L TENSOR REMARK 3 L11: 6.1622 L22: 4.1484 REMARK 3 L33: 6.4611 L12: 0.6312 REMARK 3 L13: 3.6630 L23: 1.0830 REMARK 3 S TENSOR REMARK 3 S11: -0.0081 S12: -0.0396 S13: -0.1794 REMARK 3 S21: 0.0292 S22: 0.0180 S23: -0.0677 REMARK 3 S31: 0.1090 S32: -0.0461 S33: -0.0098 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 201 A 201 REMARK 3 ORIGIN FOR THE GROUP (A): 35.5156 49.9485 36.0279 REMARK 3 T TENSOR REMARK 3 T11: -0.1261 T22: -0.1051 REMARK 3 T33: -0.1282 T12: 0.0190 REMARK 3 T13: 0.0032 T23: 0.0079 REMARK 3 L TENSOR REMARK 3 L11: 1.6587 L22: 5.9961 REMARK 3 L33: 5.0155 L12: -1.1780 REMARK 3 L13: -0.9546 L23: -1.2714 REMARK 3 S TENSOR REMARK 3 S11: 0.0162 S12: -0.2242 S13: -0.1732 REMARK 3 S21: 0.1152 S22: 0.0235 S23: 0.0742 REMARK 3 S31: 0.1190 S32: -0.0359 S33: -0.0397 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4DRI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1000070691. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9788 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.1 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41315 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 67.787 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : 0.04300 REMARK 200 FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.37700 REMARK 200 R SYM FOR SHELL (I) : 0.37700 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1FAP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.1 M NACL, 0.1M HEPES REMARK 280 -NAOH PH 7.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.75150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.89350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.77700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.89350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.75150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.77700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 ALA A -2 REMARK 465 MET A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 THR A 3 REMARK 465 ASP A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 ALA A 7 REMARK 465 LYS A 8 REMARK 465 ASN A 9 REMARK 465 ASN A 10 REMARK 465 GLU A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 PRO A 14 REMARK 465 THR A 15 REMARK 465 ALA A 16 REMARK 465 THR A 17 REMARK 465 VAL A 18 REMARK 465 ALA A 19 REMARK 465 LYS B 2113 REMARK 465 GLN B 2114 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 44 CG CD OE1 OE2 REMARK 470 GLU A 45 CG CD OE1 OE2 REMARK 470 GLU A 140 CG CD OE1 OE2 REMARK 470 ARG B2060 CG CD NE CZ NH1 NH2 REMARK 470 GLN B2063 CG CD OE1 NE2 REMARK 470 GLN B2072 CG CD OE1 NE2 REMARK 470 ARG B2110 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 2032 O HOH B 2276 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B2109 NE - CZ - NH1 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 112 -113.71 -137.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 43 GLU A 44 136.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RAP A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DRH RELATED DB: PDB REMARK 900 RELATED ID: 4DRJ RELATED DB: PDB DBREF 4DRI A 1 140 UNP Q13451 FKBP5_HUMAN 1 140 DBREF 4DRI B 2025 2114 UNP P42345 MTOR_HUMAN 2025 2114 SEQADV 4DRI GLY A -3 UNP Q13451 EXPRESSION TAG SEQADV 4DRI ALA A -2 UNP Q13451 EXPRESSION TAG SEQADV 4DRI MET A -1 UNP Q13451 EXPRESSION TAG SEQADV 4DRI GLY A 0 UNP Q13451 EXPRESSION TAG SEQADV 4DRI GLY B 2017 UNP P42345 EXPRESSION TAG SEQADV 4DRI ALA B 2018 UNP P42345 EXPRESSION TAG SEQADV 4DRI MET B 2019 UNP P42345 EXPRESSION TAG SEQADV 4DRI ASP B 2020 UNP P42345 EXPRESSION TAG SEQADV 4DRI PRO B 2021 UNP P42345 EXPRESSION TAG SEQADV 4DRI GLU B 2022 UNP P42345 EXPRESSION TAG SEQADV 4DRI PHE B 2023 UNP P42345 EXPRESSION TAG SEQADV 4DRI MET B 2024 UNP P42345 EXPRESSION TAG SEQRES 1 A 144 GLY ALA MET GLY MET THR THR ASP GLU GLY ALA LYS ASN SEQRES 2 A 144 ASN GLU GLU SER PRO THR ALA THR VAL ALA GLU GLN GLY SEQRES 3 A 144 GLU ASP ILE THR SER LYS LYS ASP ARG GLY VAL LEU LYS SEQRES 4 A 144 ILE VAL LYS ARG VAL GLY ASN GLY GLU GLU THR PRO MET SEQRES 5 A 144 ILE GLY ASP LYS VAL TYR VAL HIS TYR LYS GLY LYS LEU SEQRES 6 A 144 SER ASN GLY LYS LYS PHE ASP SER SER HIS ASP ARG ASN SEQRES 7 A 144 GLU PRO PHE VAL PHE SER LEU GLY LYS GLY GLN VAL ILE SEQRES 8 A 144 LYS ALA TRP ASP ILE GLY VAL ALA THR MET LYS LYS GLY SEQRES 9 A 144 GLU ILE CYS HIS LEU LEU CYS LYS PRO GLU TYR ALA TYR SEQRES 10 A 144 GLY SER ALA GLY SER LEU PRO LYS ILE PRO SER ASN ALA SEQRES 11 A 144 THR LEU PHE PHE GLU ILE GLU LEU LEU ASP PHE LYS GLY SEQRES 12 A 144 GLU SEQRES 1 B 98 GLY ALA MET ASP PRO GLU PHE MET GLU MET TRP HIS GLU SEQRES 2 B 98 GLY LEU GLU GLU ALA SER ARG LEU TYR PHE GLY GLU ARG SEQRES 3 B 98 ASN VAL LYS GLY MET PHE GLU VAL LEU GLU PRO LEU HIS SEQRES 4 B 98 ALA MET MET GLU ARG GLY PRO GLN THR LEU LYS GLU THR SEQRES 5 B 98 SER PHE ASN GLN ALA TYR GLY ARG ASP LEU MET GLU ALA SEQRES 6 B 98 GLN GLU TRP CYS ARG LYS TYR MET LYS SER GLY ASN VAL SEQRES 7 B 98 LYS ASP LEU THR GLN ALA TRP ASP LEU TYR TYR HIS VAL SEQRES 8 B 98 PHE ARG ARG ILE SER LYS GLN HET RAP A 201 65 HETNAM RAP RAPAMYCIN IMMUNOSUPPRESSANT DRUG FORMUL 3 RAP C51 H79 N O13 FORMUL 4 HOH *223(H2 O) HELIX 1 1 HIS A 71 ASN A 74 5 4 HELIX 2 2 ILE A 87 ALA A 95 1 9 HELIX 3 3 PRO A 109 ALA A 112 5 4 HELIX 4 4 GLU B 2022 GLY B 2040 1 19 HELIX 5 5 ASN B 2043 GLU B 2059 1 17 HELIX 6 6 THR B 2064 GLY B 2092 1 29 HELIX 7 7 ASN B 2093 SER B 2112 1 20 SHEET 1 A 6 GLU A 23 ASP A 24 0 SHEET 2 A 6 VAL A 33 ARG A 39 -1 O LYS A 35 N GLU A 23 SHEET 3 A 6 ILE A 102 CYS A 107 -1 O ILE A 102 N LYS A 38 SHEET 4 A 6 LEU A 128 LYS A 138 -1 O LEU A 128 N CYS A 107 SHEET 5 A 6 LYS A 52 LEU A 61 -1 N LYS A 60 O PHE A 129 SHEET 6 A 6 LYS A 66 SER A 69 -1 O PHE A 67 N GLY A 59 SHEET 1 B 6 GLU A 23 ASP A 24 0 SHEET 2 B 6 VAL A 33 ARG A 39 -1 O LYS A 35 N GLU A 23 SHEET 3 B 6 ILE A 102 CYS A 107 -1 O ILE A 102 N LYS A 38 SHEET 4 B 6 LEU A 128 LYS A 138 -1 O LEU A 128 N CYS A 107 SHEET 5 B 6 LYS A 52 LEU A 61 -1 N LYS A 60 O PHE A 129 SHEET 6 B 6 PHE A 77 SER A 80 -1 O PHE A 79 N VAL A 53 CISPEP 1 LEU A 119 PRO A 120 0 2.37 SITE 1 AC1 26 TYR A 57 PHE A 67 ASP A 68 ARG A 73 SITE 2 AC1 26 PHE A 77 GLY A 84 GLN A 85 VAL A 86 SITE 3 AC1 26 ILE A 87 TRP A 90 TYR A 113 ILE A 122 SITE 4 AC1 26 PHE A 130 HOH A 316 HOH A 353 HOH A 366 SITE 5 AC1 26 HOH A 386 LEU B2031 GLU B2032 SER B2035 SITE 6 AC1 26 PHE B2039 THR B2098 ASP B2102 TYR B2105 SITE 7 AC1 26 PHE B2108 HOH B2219 CRYST1 59.503 59.554 67.787 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016806 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016791 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014752 0.00000